Format

Send to

Choose Destination
Bioorg Med Chem Lett. 1999 Jul 19;9(14):2115-8.

Tetrapeptide derived inhibitors of complexation of a class II MHC: fully unnatural ligands.

Author information

1
Department of Basic Medicinal Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA.

Abstract

Tetrapeptide derived major histocompatability (MHC) II ligands have been developed that contain no unadulterated peptide bonds. These are the 'least peptidic' ligands for any MHC protein yet reported.

PMID:
10450992
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center